Clinical significance of combined detection of plasma CD146 and P-selectin in patients with type 2 diabetic nephrophathy

WANG Feng,WANG Nian-song,GAO Xu-ping,FAN Ying
DOI: https://doi.org/10.3969/j.issn.1003-6350.2012.11.043
2012-01-01
Abstract:Objective To investigate the clinical significance of CD146 and P-selectin in peripheral blood in patients with type 2 diabetic nephrophathy. Methods A total of 80 patients with type 2 diabetes nephrophathy were randomized into the diabetes group (DN0 group), micro-albuminuria group (DN1 group), Macro-albuminuria uria group (DN2 group) and renal insufficiency group (DN3 group), with 20 cases in each group. Twenty healthy individuals were enrolled as the control group (Non-DM group). ELISA was used to detect the expression of CD146 and P-selectin. Results The levels of CD146 and P-selectin in DN0 group was significantly higher than those in Non-DM group [(319.6±15.9) ng/ml and (57.9±3.1) ng/ml vs (243.5±14.7) ng/ml and (45.3±2.7) ng/ml, respectively], P<0.05. In DN1 group, DN2 group and DN3 group, the levels of CD146 and P-selectin was significantly higher than those in DN0 group (P<0.05). The levels of CD146 in the three groups were (415.3±29.0) ng/ml, (486.6±34.3) ng/ml and (515.9±36.9) ng/ml, respectively, and the levels of P-selectin were (66.8±3.4) ng/ml, (79.6±4.6) ng/ml and (81.5 ± 5.1) ng/ml, respectively. Conclusion Expression of CD146 and P-selectin in patients with type 2 diabetic nephrophathy is elevated with the progression of diabetic nephropathy.
What problem does this paper attempt to address?